NIAID | Technology Transfer

Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines

Read more about Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines

Japan
2013-544747
Filed on 2011-12-14

Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines

Read more about Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines

India
5348/CHENP/2013
Filed on 2011-12-14

Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines

Read more about Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines

China
201180067429.7
Filed on 2011-12-14

Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines

Read more about Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines

Canada
2821289
Filed on 2011-12-14

Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines

Read more about Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines

Brazil
BR112013014712-1
Filed on 2011-12-14

Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines

Read more about Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines

Australia
2011343798
Filed on 2011-12-14

Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3-UTR Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

Read more about Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3-UTR Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

US Patent RE46641
Filed on 2013-05-17

Development Of Dengue Virus Vaccine Components

Read more about Development Of Dengue Virus Vaccine Components

US Patent RE046,042
Filed on 2013-05-16

Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-UTR Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

Read more about Dengue Tetravalent Vaccine Containing A Common 30 Nucleotide Deletion In The 3'-UTR Of Dengue Types 1,2,3, And 4, Or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

US Patent RE46,631
Filed on 2013-05-17

Recombinant Attenuated Dengue Viruses Comprising A Deletion in the 3' Untranslated Region and Additional Attenuating Mutations Induced by Chemical Mutagenesis

Read more about Recombinant Attenuated Dengue Viruses Comprising A Deletion in the 3' Untranslated Region and Additional Attenuating Mutations Induced by Chemical Mutagenesis

US Patent RE45,123
Filed on 2013-05-17

Subscribe to NIAID